Sexual, Physical, And Overall Adverse Effects In Patients Treated With 5α-Reductase Inhibitors: A Systematic Review And Meta-Analysis

    October 2021 in “ Asian Journal of Andrology
    Junjie Zhang, Xiao Shi, Ting Wu, Mengda Zhang, Jin Tang, Guangming Yin, Zhi Li, Leye He, Lin Qi, Long Wang
    Image of study
    TLDR Medications for hair loss and prostate issues can significantly increase the risk of sexual side effects and other negative symptoms.
    This systematic review and meta-analysis of 34 studies with 25,696 subjects found that 5α-reductase inhibitors (5ARIs), used for treating androgenetic alopecia (AGA) and benign prostatic hyperplasia (BPH), significantly increase the risk of post-finasteride syndrome (PFS)-like adverse effects, particularly sexual adverse effects. The overall use of 5ARIs was associated with a 1.87-fold risk of PFS-like adverse effects. Specific types of 5ARIs, such as 5 mg/day finasteride, 1 mg/day finasteride, and 0.5 mg/day dutasteride, had a 1.85-fold, 2.08-fold, and 2.01-fold risk respectively. Patients treated for AGA or BPH had a 1.49-fold risk of PFS-like adverse effects compared to placebo. The study suggests that clinicians should assess the risk of preexisting mental health issues and potential sexual dysfunction before 5ARI treatment, and consider alternative treatments to protect patients from the immediate and persistent adverse effects of 5ARIs.
    Discuss this study in the Community →

    Research cited in this study

    30 / 30 results

    Related Community Posts Join

    6 / 92 results

      community 1 month of using fin, so happy

      in Progress Pictures  862 upvotes 4 months ago
      User had a hair transplant and used a finasteride and minoxidil spray for 6 months with no results. After adding finasteride tablets for 1 month, they saw significant hair growth improvement.

      community Hair Loss Drugs Ranked in Order of Efficacy

      in Research/Science  67 upvotes 1 year ago
      Dutasteride is likely the most effective treatment for male pattern baldness, followed by finasteride and minoxidil in various forms and dosages. Users discuss personal experiences, dosages, and potential side effects, with some considering combining treatments for better results.
      FCE 28260: A Forgotten 5α-Reductase Inhibitor

      community FCE 28260: A Forgotten 5α-Reductase Inhibitor

      in Research  330 upvotes 3 months ago
      FCE 28260 (PNU 156765), an under-explored 5α-reductase inhibitor, showcases promising results in research by Giudici et al., outperforming well-known treatments like Finasteride in reducing the conversion of testosterone to DHT. Its superior efficacy, demonstrated through lower IC50 values in both natural and human recombinant enzyme studies, suggests it could offer more effective management of DHT-related conditions. Additionally, its lower molecular weight hints at better potential for topical application, potentially offering advantages in treating conditions such as androgenic alopecia. Despite its potential, it has not advanced in development, possibly due to financial limitations, leaving its therapeutic prospects and side effect profile largely unexplored.

      community Another clueless guy fearmongering and spreading misinformation

      in Chat  251 upvotes 10 months ago
      The conversation discusses hair loss treatments, with some users advocating for finasteride and minoxidil, while others express concerns about potential side effects of finasteride. A social media influencer is criticized for promoting scalp massages and minoxidil over finasteride, which some believe is misinformation.

    Similar Research

    6 / 1000+ results